NEW YORK--(BUSINESS WIRE)--Accenture (NYSE:ACN) has announced the launch of Accenture Life Sciences Cloud for R&D which speeds clinical development, helps improve patient outcomes and creates greater R&D efficiency through a new single analytics platform that brings together multiple internal and external data sources across clinical, safety, regulatory and operational functions.
In parallel with the Accenture Life Sciences Cloud for R&D platform, Accenture has formed a Life Sciences Cloud Coalition, which includes Eisai, Merck and Pfizer. The aim of this group is to collaborate on bringing innovation to the Accenture Life Sciences Cloud and digitally enable the R&D function, speed up the drug development process while improving quality and cost for the industry.
Help employers find you! Check out all the jobs and post your resume.
In parallel with the Accenture Life Sciences Cloud for R&D platform, Accenture has formed a Life Sciences Cloud Coalition, which includes Eisai, Merck and Pfizer. The aim of this group is to collaborate on bringing innovation to the Accenture Life Sciences Cloud and digitally enable the R&D function, speed up the drug development process while improving quality and cost for the industry.
Help employers find you! Check out all the jobs and post your resume.
